Skip to content
2026 Agenda

Day 1

8:45

2026 Program Introduction

Greg Robinson, M.Sc., CMD, RTT, Sun Nuclear, a Mirion Medical Company, United States

Future Directions of Machine and Patient QA

9:00

Keynote Presentation: Independent Measurements vs MPC

David Barbee, Ph.D., DABR, NYU Langone Health, United States

9:30

Efficiency in Action: Using the Right Tools to Optimize QA and Treatment Accuracy

Patricia Sansourekidou, Ph.D., DABR, University of New Mexico Comprehensive Cancer Center, United States

10:00

Maintaining Long-Term Isocenter Stability and Subcomponent Alignment in TrueBeam Linear Accelerators

Cory Knill, Ph.D., DABR, University of Michigan, United States

10:15

BREAK

10:45

DEBATE: Does Properly Commissioned Delivery Techniques Render Routine Measurement PSQA Obsolete?

Dirk Verellen, Ph.D., Iridium Netwerk, ZAS & Victor Hernandez Masgrau, Ph.D., Hospital Universitari Sant Joan de Reus

11:30

Patient Specific QA Survey and Guidelines

Gordon Chan, Ph.D., MCCPM, Juravinski Cancer Center, Canada

12:00

Panel Discussion: Future QA Directions

Moderators: Dirk Verellen, Ph.D., Victor Hernandez, Ph.D., and Gordon Chan

12:30

LUNCH

In-vivo Dosimetry and SRS/SBRT QA

13:30

In-vivo Dose Measurements Over Time as QA Indicator

Cristina Anson Marcos, M.Sc., Hospital de la Santa Creu i Sant Pau, Spain

13:45

Validation of Transit Dosimetry Metrics

Nadezhda Gromova, JSC European Medical Center, Russian Federation

14:00

EPID-Based In-Vivo Dosimetry for TBI

Matteo Galetto, M.Sc., Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Italy

14:15

Clinical Utility of Gamma Pass Rate for Adaptive Replanning in Lung Cancer Radiotherapy

Yoshiko Oshiro, Ph.D., Tsukuba Medical Center Hospital, Japan

14:30

Comparing In-vivo Dosimetry with Offline Dosimetric Assessments as a Trigger for Adaptive Intervention of Pelvic Radiotherapy

Natalie Brown, Hull University Teaching Hospitals NHS Trust, United Kingdom

14:45

Investigating the Correlation Between Gamma Passing Rates of Daily EPID Transit Images and PTV Coverage in External Beam Radiotherapy

Ruslan Huseynov, M.Sc., North West Cancer Centre, Altnagelvin Hospital, United Kingdom

15:00

Panel Discussion: In-vivo QA in Adaptive Workflows

Moderators: Yoshiko Oshiro, Ph.D., Natalie Brown and Ruslan Huseynov

15:30

BREAK

Safety, QC & Guidelines; Using the Right Tool for the Job

16:00

Comparing Methods of Pretreatment Quality Assurance in Modulated Radiation Therapy: Portal Dosimetry vs. Fraction 0

Federico Bregains, M.Sc., CEMENER Foundation, Argentina

16:30

RapidArc Dynamic for SBRT

Robert Brass, M.Sc., The Clatterbridge Cancer Centre, United Kingdom

16:45

Characterizing the Error-Space of SIMT-SRS: What Tolerance Do We Need?”

Anton Eagle, M.S., DABR, AdventHealth, Parker, United States

17:00

Clinical Feasibility of SGRT for Multi-Target SRS: Integrated Geometric and Dosimetric Validation

Thiago Schmeling, M.Sc., São Sebastião Radioterapia, Brazil

18:00

NETWORKING RECEPTION


2026 Agenda

Day 2

Emerging Technologies: Theranostics

9:00

PDIB Project for Standardizing Clinical RPT Practice

John Sunderland, PhD., University of Iowa, United States

9:30

QA in Molecular Radiotherapy dosimetry?

Manuel Bardies, Ph.D., INSERM, France

9:45

Emerging Technologies: Theranostics and AI/Automation

Lidia Strigari, Ph.D., M.Sc, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Italy

10:00

Panel Discussion: Theranostics

Moderators: John Sunderland, PhD., MBA, Manuel Bardies, Ph.D., Lidia Strigari, Ph.D., M.Sc

10:30

BREAK

Emerging Technologies: AI and Automation

11:00

Automated Generation of High-Quality Prostate SBRT Plans Using Pre-Plan Feasibility Physics-Based DVH Driven Optimization

Garrett Baltz, M.S., DABR, Scripps Cancer Center, United States

11:30

AI-Driven Troubleshooting for TrueBeam Systems: Enhancing Clinical Efficiency and Safety with a GPT-4o Chatbot

Cory Knill, Ph.D., DABR, University of Michigan, United States

12:00

LUNCH

13:00

From Data to Decisions: Cloud AI for Smarter RT Quality Assurance and Automation

Todd McNutt, Ph.D., DABR, Johns Hopkins University, United States

13:30

Leveraging Personalized DVH Predictions for Better Plans and Increased Quality

Christian Velten, Ph.D., DABR, DABMP Montefiore Medical Center, United States

14:00

What Impacts Automation Bias in Auto Contouring

Paul Doolan, Ph.D., German Oncology Center, Cyprus

14:30

General versus Site Specific Quantile Random Forest Models for Virtual Patient-Specific Quality Assurance of VMAT Plans

Naila Rahman, Ph.D., Sunnybrook Health Sciences Center, Canada

15:00

Panel Discussion: AI & Automation

Moderators: Todd McNutt, Ph.D., DABR, Christian Velten, Ph.D., DABR, Garrett Baltz, M.S., DABR, Cory Knill, Ph.D., DABR, Paul Doolan, Ph.D., Naila Rahman, Ph.D.

15:45

Closing Remarks